Newsletter March 2024 No.220
Top News
JAPIA Presidents' Press Conference" held Aiming to be a country where innovation is dynamic
On February 15, 2024, the "Pharmaceutical Association of Japan (PSA) Presidents Press Conference" was held at Bellesalle Iidabashi Station (Chiyoda-ku, Tokyo) in a hybrid format of on-site participation and online. At the beginning of the press conference, Hiroaki Ueno, Chairman of the Pharmaceutical Manufacturers Association of Japan (PMAJ), expressed his condolences for the Noto Peninsula Earthquake of 2024, which occurred on January 1, 2024, and then gave a presentation titled "Toward a Nation Dynamic in Innovation". In his presentation, he explained the importance of proper evaluation of innovation and the direction of the pharmaceutical industry's efforts to strengthen Japan's drug discovery capabilities, and engaged in a lively Q&A session with the 35 members of the press from 21 companies who attended the event. The following is a summary of Chairman Ueno's presentation and the Q&A session.
Topics
- Rare Disease Day 2024 Symposium" held by the Pharmaceutical Manufacturers Association of Japan
- The 4th Japan-Vietnam Joint Symposium" was held
- The 5th ICH Forum: ICH Quality Guideline Update
- Joint Conference on Global Health 2023" held Co-hosted symposium on "Drug Resistance (AMR) as a Global Health Issue
- Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
- The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
- Held a regular meeting with the French Association of the Pharmaceutical Industry (Leem).
- CMC Strategy Forum Japan 2023" held
- Workshop on "Next Generation Adverse Reaction Case Evaluation Workshops" was held
Policy Research Institute page
Comparison of New Drug Approval Status and Review Periods in Japan, the U.S. and Europe (2022)
From JPMA
Aiming for a country where innovation is dynamic